-
![Farmaseutyske grûnstoffen en intermediates |Diabetes |3-(trifluormethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride |CAS No.762240-92-6](https://www.yisunbio.com/uploads/pgy-Ce1.jpg)
Farmaseutyske grûnstoffen en intermediates |Diabetes |3-(trifluormethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride |CAS No.762240-92-6
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Aktive Pharmaceutical Ingredient Intermediates |Diabetes |3-(trifluormethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride|CAS: 762240-92-6
-
Farmaseutyske grûnstoffen en intermediates |Diabetes |Boc-(R)-3-Amino-4-(2,4,5-trifluorfenyl)butanoic acid |CAS No.486460-00-8
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Aktive Pharmaceutical Ingredient Intermediates |Diabetes |Boc-(R)-3-Amino-4-(2,4,5-trifluorfenyl)butanoic acid |CAS: 486460-00-8